Core Viewpoint - NMN (β-Nicotinamide Mononucleotide) is gaining attention in the global health industry for its potential anti-aging, DNA repair, and metabolic regulation benefits, with significant developments in regulatory approval and market potential expected by 2025 [1][2]. Industry Development - The NMN industry has evolved from laboratory research to commercial applications, with major markets like the US, Japan, Canada, and Australia recognizing its legal status through various regulatory pathways [1][2]. - China is currently the largest producer of NMN raw materials, with leading companies building competitive barriers through technological innovation and industry chain layout [2]. NMN Definition and Function - NMN is a direct precursor to NAD+ (Nicotinamide Adenine Dinucleotide), crucial for delaying aging and enhancing physiological functions [3][4]. - Supplementing NMN can quickly elevate NAD+ levels in the body, playing a vital role in anti-aging, cardiovascular health, and metabolic improvement [4]. Synthesis Pathways - NMN supplementation shows significant advantages in NAD+ synthesis pathways compared to other precursors, with the highest conversion efficiency and no known adverse effects [6][7]. Natural Sources and Supplementation - Natural food sources of NMN are limited, making NMN supplements, which can provide up to 300 times the intake from dietary sources, more effective [8]. Synthesis Technology - The NMN synthesis process has shifted from chemical methods to fully enzymatic methods, which are safer, more efficient, and environmentally friendly [10][11]. - Leading companies are innovating in full enzymatic synthesis technology, creating competitive advantages through patent applications [12]. Market Trends and Drivers - The demand for NMN is driven by an aging population and increasing awareness of anti-aging among younger demographics, creating a dual market push [19]. - Technological advancements in synthesis, quality testing, and delivery methods are driving the NMN industry towards scale, standardization, and efficiency [21][22]. Application Areas - NMN is primarily used in health supplements and cosmetics, with potential future applications in pet nutrition, medical health, and agricultural technology [24][28]. - The NMN market in China is expected to exceed 3 billion yuan by 2025, with significant growth anticipated as regulatory barriers are lifted [28]. Sales Channels - NMN products are mainly sold through cross-border e-commerce and private channels, with cross-border platforms accounting for 60%-70% of market share [35]. Certification and Compliance - The "blue hat" certification for health supplements in China represents the highest standard for NMN products, with strict approval processes that could reshape the market landscape if achieved [37]. Challenges and Opportunities - The NMN industry faces challenges such as exaggerated claims, lack of consumer awareness, and technological iterations, necessitating compliance and innovation for long-term competitiveness [61][63]. - Companies are encouraged to innovate their business models, extending from raw material supply to comprehensive service providers across the entire industry chain [66].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company achieved a total revenue of 9.18 billion yuan in 2025, representing a year-on-year increase of 35% [7] - The net profit for 2025 was 1.15 billion yuan, with a year-on-year growth of 44%, falling within the upper range of the forecast [7] - The company's gross margin for 2025 was 76%, an increase of 1.2 percentage points year-on-year, indicating stable profitability [7] - Online self-operated sales grew significantly, with total online revenue reaching 8.62 billion yuan, a year-on-year increase of 40.1% [7] - The main brand, Han Shu, generated revenue of 7.36 billion yuan, a year-on-year increase of 31.6%, maintaining its leading position in the beauty market [7] - The multi-brand strategy is showing strong performance, with the new brand Newpage achieving revenue of 880 million yuan, a year-on-year increase of 134.2% [7] - The company has signed a cooperation agreement for a new whitening agent, which is expected to enhance its competitive edge in the market [7] - The profit forecasts for 2026 and 2027 have been slightly adjusted to 1.38 billion yuan and 1.72 billion yuan, respectively, with a new forecast for 2028 at 2.15 billion yuan [7] Financial Summary - Total revenue projections for 2024A, 2025A, 2026E, 2027E, and 2028E are 6.79 billion, 9.18 billion, 11.47 billion, 14.32 billion, and 17.68 billion yuan, respectively [1] - Net profit projections for the same years are 781.21 million, 1.10 billion, 1.38 billion, 1.72 billion, and 2.15 billion yuan, respectively [1] - The latest diluted EPS for 2025 is projected at 2.77 yuan per share, with a P/E ratio of 19.05 [1]

Investment Rating - The report maintains a "Buy" rating for the company [6] Core Insights - The company is experiencing a phase of performance pressure, with revenue for the first three quarters of 2025 at 2.597 billion yuan, a year-over-year decrease of 7.34%, and a net profit attributable to shareholders of 142 million yuan, down 17.19% year-over-year [1] - The cosmetics segment shows strong performance from the Yilian and Kemi brands, while the Ai'er Doctor brand is undergoing adjustments [1] - The pharmaceutical segment is accelerating its layout in the food-medicine integration field, with a revenue of 305 million yuan in the first three quarters of 2025, down 17.46% year-over-year [2] - The raw materials and additives segment has shown growth, with revenue of 276 million yuan, an increase of 11.19% year-over-year [2] - The company is focusing on upgrading its health business and optimizing its product mix and channel strategies in the cosmetics sector [3] Financial Summary - Revenue projections for 2025-2027 are adjusted to 3.869 billion, 4.131 billion, and 4.477 billion yuan, with year-over-year changes of -2.9%, +6.8%, and +8.4% respectively [3] - Net profit forecasts for the same period are 240 million, 274 million, and 318 million yuan, with year-over-year changes of -1.6%, +14.5%, and +15.8% respectively [3] - The company’s current P/E ratio for 2026 is projected at 24.4x [3]

Core Viewpoint - The article emphasizes the importance of sun protection and effective whitening products to prevent skin darkening and pigmentation, highlighting a specific product, the Pianzaihuang Queen's Brightening Cream 2.0, as a high-value option for consumers [9][11][12]. Group 1: Product Features - The Pianzaihuang Queen's Brightening Cream 2.0 contains multiple whitening ingredients such as niacinamide and tranexamic acid, which work together to lighten skin and reduce pigmentation [13][62]. - The cream also includes moisturizing components like cocoa seed butter, panthenol, and glycerin, ensuring hydration while providing whitening effects [15][74]. - It has received a special approval certificate for its whitening claims, indicating regulatory compliance and effectiveness [17][20]. Group 2: Market Position - Pianzaihuang is recognized as a well-established domestic skincare brand with a long-standing reputation for affordability and effectiveness, making it a popular choice among consumers [24][25][37]. - The product is priced competitively at 158 yuan for a buy-one-get-one-free offer, making it accessible compared to other high-end brands [31][101]. - The brand's marketing strategy relies more on word-of-mouth and consumer trust rather than heavy advertising, contributing to its strong market presence [38][41]. Group 3: Consumer Feedback - Many users report positive results, including improved skin tone and reduced pigmentation, reinforcing the product's effectiveness [46][50]. - The cream's lightweight texture and hydrating properties make it suitable for various skin types and seasonal use [94][97]. - Consumers appreciate the product's dual function as both a whitening and moisturizing cream, enhancing its appeal [89][99].

Core Viewpoint - Lin Qingxuan, as the only domestic representative among China's top 15 high-end skincare brands, achieved remarkable growth with a revenue of 2.45 billion and a year-on-year increase of 102.5% in 2025, standing out in a market that reached 1.1 trillion with a growth rate of 2.83% [2][26]. Group 1: Revenue Growth Drivers - The first driver of Lin Qingxuan's high growth is its successful flagship product strategy, with at least three billion-level flagship products contributing significantly to revenue, including the Camellia Oil generating 1.024 billion, accounting for 41.8% of total revenue [2][4]. - The second driver is the dual-channel strategy, with online revenue increasing by 1.01 billion, a year-on-year growth of 140%, while offline channels also showed impressive growth without expanding new types of channels [4][9]. Group 2: Channel Strategy - In 2025, Lin Qingxuan's online revenue reached 1.724 billion, growing by 141.46%, while offline revenue was 725 million, with a year-on-year increase of 46.55%, shifting the online-offline ratio from 60:40 to 70:30 [9][10]. - The company emphasizes the importance of offline channels for building long-term consumer trust and loyalty, viewing offline stores as a "trust space" essential for brand development [9][12]. Group 3: Online and Offline Performance - Online, Lin Qingxuan's revenue from Douyin reached 960 million, a staggering growth of 338%, making it the largest channel, while Tmall and WeChat also contributed 240 million and 190 million respectively [10][12]. - Offline, Lin Qingxuan's store revenue was 576 million, with a 30% year-on-year increase, and the number of direct stores grew from 342 to 390, totaling 580 nationwide [12][25]. Group 4: Marketing and Brand Building - Lin Qingxuan's marketing strategy includes a "short video + live broadcast" model, effectively converting traffic into sales through engaging content and interactive experiences [15][19]. - The brand has established a "brand IP matrix" led by its founders, targeting different consumer segments and enhancing emotional connections through diverse communication styles [18][19]. Group 5: Customer Retention and Market Position - Lin Qingxuan has over 6.1 million active customers and maintains a high annual repurchase rate of 34.2%, indicating a sustainable user relationship maintenance system [25]. - The brand's strategy of combining online reach with offline depth has proven effective in building trust and loyalty, essential for long-term brand value [25][26].

Investment Rating - Investment rating: "Outperform" (maintained) [5] Core Views - The company is a leading player in the skincare ODM sector, with a projected revenue growth of 21% in 2025 [3][7] - The company reported a revenue of 842 million yuan in 2025, a year-on-year increase of 21.15%, while the net profit attributable to the parent company was 38.74 million yuan, a decline of 14.64% year-on-year [7] - The company continues to implement a large client and large product strategy, increasing market expansion efforts and enhancing product competitiveness [8] Financial Summary - Revenue projections for 2025-2027 are 842 million yuan, 1.148 billion yuan, and 1.316 billion yuan, respectively, with corresponding net profits of 39 million yuan, 80 million yuan, and 101 million yuan [10] - The gross margin is expected to decline to 23% in 2025, with a recovery to 27.2% by 2027 [10][13] - The company has a total market capitalization of 1.353 billion yuan and a circulating market capitalization of 772 million yuan [5] Market Position and Recognition - The company was included in the first batch of "white list" enterprises for customs clearance convenience in Guangzhou and was awarded "Most Innovative ODM Enterprise" in 2026 [9] - Guangzhou's cosmetics industry is a leading city in China, with an annual output value exceeding 100 billion yuan, and the company benefits from favorable policies supporting high-quality development in the beauty industry [9]

Investment Rating - The report indicates a positive investment outlook for the sunscreen industry, projecting a market size growth from 8.5 billion to 22.4 billion by 2028, reflecting a clear expansion trend [9][10]. Core Insights - The sunscreen market in China is experiencing a shift from explosive growth to a more stable, demand-driven expansion, with a notable increase in multifunctional products that combine skincare benefits with sun protection [11][12]. - Consumer awareness regarding sunscreen usage has significantly increased, with over 70% of consumers using sunscreen frequently, indicating a shift from situational to daily skincare necessity [14][15]. - The online sales of sunscreen products are expected to grow steadily from 2023 to 2025, with a notable increase in sales and volume, particularly on platforms like Douyin [17][19]. Market Overview - The sunscreen market is categorized into physical, chemical, and hybrid formulations, each with distinct advantages and disadvantages, catering to different consumer needs [7][8]. - The market size is projected to grow from 8.5 billion in 2015 to 22.4 billion by 2028, with a compound annual growth rate (CAGR) indicating a shift towards refined consumer demands [9][10]. Product Performance - Basic sunscreen efficacy has seen a decline of 6%, while additional skincare benefits such as moisturizing, repairing, and soothing have shown significant growth rates of 15%, 45%, and 116% respectively, highlighting a shift in consumer preferences towards multifunctional products [11][12]. - The average price of sunscreen products varies, with basic sunscreen averaging 121 yuan, while products with added benefits like moisturizing and repairing are priced higher, reflecting their perceived value [12]. Consumer Behavior - The report highlights that consumers prioritize protection effectiveness, safety, and skin feel when purchasing sunscreen, with additional benefits and environmental attributes being secondary considerations [14][15]. - The frequency of sunscreen application is high, with 87% of consumers aware of the need for reapplication, particularly during outdoor activities [14][15]. Online Sales Trends - The online market for sunscreen is expected to see dual growth in sales and volume from 2023 to 2025, with Douyin emerging as a key player, surpassing traditional platforms like Taobao in growth rates [17][19]. - The average price of sunscreen products on Douyin is increasing, indicating a shift towards higher-end products, while Taobao has experienced fluctuations in pricing [19][21]. Brand Dynamics - The brand landscape in the sunscreen category shows a concentration of market share among top brands, with Mistine leading in both Taobao and Douyin platforms, while new and domestic brands are gaining traction [29][30]. - The competitive dynamics differ between platforms, with Taobao showing higher brand concentration and Douyin exhibiting a more fragmented market with rapid growth among emerging brands [29][31].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][11] Core Insights - The company reported a revenue increase of 30.0% year-on-year for 2025, reaching 5.05 billion yuan, and a net profit increase of 36.8%, amounting to 1.205 billion yuan. The brand's momentum continues to be strong, leading to an upward revision of profit forecasts for 2026-2028 [4][5] - The company expects net profits for 2026, 2027, and 2028 to be 1.587 billion, 1.978 billion, and 2.457 billion yuan respectively, with corresponding EPS of 3.24, 4.04, and 5.01 yuan. The current stock price corresponds to P/E ratios of 19.0, 15.2, and 12.2 for the respective years [4][7] Financial Performance - In 2025, the company's revenue from different segments was as follows: makeup 2.996 billion yuan (up 30.0%), skincare 1.873 billion yuan (up 31.1%), and training 147 million yuan (down 2.8%). The newly added fragrance segment generated 34 million yuan [5] - The online and offline channels generated revenues of 2.477 billion and 2.426 billion yuan respectively, with year-on-year growth of 38.8% and 24.5% [5] - The gross profit margin for 2025 was 84.2%, with slight decreases in various segments, while the overall expense ratios for sales and management showed a steady decline [5][7] Business Development - The company continues to strengthen its high-end positioning with successful product launches in the makeup and skincare segments, including significant sales from key products [6] - The company has expanded its presence in high-end retail locations and online platforms, achieving notable sales growth in e-commerce channels [6]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][11] Core Insights - The company reported a revenue increase of 30.0% year-on-year for 2025, reaching 5.05 billion yuan, and a net profit increase of 36.8%, amounting to 1.205 billion yuan. The brand's momentum continues to be strong, leading to an upward revision of profit forecasts for 2026-2028 [4][5] - The company expects net profits for 2026, 2027, and 2028 to be 1.587 billion, 1.978 billion, and 2.457 billion yuan respectively, with corresponding EPS of 3.24, 4.04, and 5.01 yuan. The current stock price corresponds to P/E ratios of 19.0, 15.2, and 12.2 for the respective years [4][7] Financial Performance - In 2025, the revenue breakdown by business segment was as follows: makeup 2.996 billion yuan (up 30.0%), skincare 1.873 billion yuan (up 31.1%), and makeup training 147 million yuan (down 2.8%). The newly added fragrance segment generated 34 million yuan [5] - Revenue from online and offline channels reached 2.477 billion and 2.426 billion yuan respectively, with year-on-year growth of 38.8% and 24.5% [5] - The gross margin for 2025 was 84.2%, with slight decreases in various segments, while the overall expense ratios for sales and management decreased to 48.3% and 5.3% respectively [5] Business Development - The company has solidified its leading position in high-end domestic makeup, with significant sales from key products such as the small gold fan powder and caviar cushion, each exceeding 300 million yuan. The skincare segment also saw strong performance with flagship products achieving over 1 billion yuan in retail sales [6] - The company is expanding its high-end channel presence and has opened new stores in prestigious locations, enhancing its brand positioning. The online sales channels are also performing well, with significant growth expected to continue [6]

Investment Rating - The report assigns a rating of "Accumulate" for the company [5]. Core Insights - The company is expected to achieve revenue and net profit growth of 35% and 44% year-on-year in 2025, respectively, with accelerated growth in the second half of the year [1]. - The brands Han Shu and Yi Ye are projected to have revenue growth of 32% and 134% year-on-year, respectively, indicating a strong multi-category and multi-brand expansion strategy [1]. - The report highlights the company's robust performance in the second half of 2025, with revenue, net profit, and attributable net profit expected to reach 5.07 billion, 598 million, and 579 million RMB, respectively, reflecting year-on-year growth of 54%, 53%, and 52% [9]. Financial Summary - The total revenue for 2024 is projected at 6,793 million RMB, increasing to 9,178 million RMB in 2025, representing a growth rate of 35.1% [3]. - Gross profit is expected to rise from 5,109 million RMB in 2024 to 7,015 million RMB in 2025, with a gross margin of 76.4%, an increase of 1.2 percentage points year-on-year [9]. - The attributable net profit is forecasted to grow from 781 million RMB in 2024 to 1,103 million RMB in 2025, reflecting a year-on-year increase of 41.1% [3]. - The report anticipates a PE ratio of 15.63 for 2024, increasing to 23.13 in 2025, before declining to 10.93 by 2028 [3]. Brand Performance - The Han Shu brand is expected to achieve a revenue of 736 million RMB in 2025, with a year-on-year growth of 32%, while Yi Ye is projected to reach 88 million RMB, with a remarkable growth of 134% [9]. - The report notes that Han Shu's sales on Douyin are expected to grow by 37% year-on-year, with significant growth also seen on platforms like Kuaishou and Pinduoduo [9]. - Yi Ye's flagship product, Anxin Cream, is projected to maintain its position as the top seller with a year-on-year sales increase of 96% [9].